Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.01 EPS (ttm)5.55 Insider Own0.07% Shs Outstand2.68B Perf Week-0.35%
Market Cap386.77B Forward P/E16.70 EPS next Y8.64 Insider Trans-4.29% Shs Float2.68B Perf Month5.63%
Income15.14B PEG3.35 EPS next Q1.95 Inst Own68.20% Short Float0.54% Perf Quarter8.88%
Sales81.38B P/S4.75 EPS this Y-8.50% Inst Trans-0.07% Short Ratio2.17 Perf Half Y16.47%
Book/sh24.09 P/B5.99 EPS next Y5.77% ROA1.00% Target Price146.78 Perf Year3.41%
Cash/sh7.22 P/C19.97 EPS next 5Y7.77% ROE2.50% 52W Range118.62 - 148.32 Perf YTD3.24%
Dividend3.60 P/FCF42.36 EPS past 5Y7.10% ROI15.70% 52W High-2.74% Beta0.57
Dividend %2.50% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.50% 52W Low21.61% ATR2.45
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.40% RSI (14)61.84 Volatility1.35% 1.79%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.90% Rel Volume0.98 Prev Close144.68
ShortableYes LT Debt/Eq0.46 EarningsOct 16 BMO Payout526.10% Avg Volume6.60M Price144.25
Recom2.30 SMA202.35% SMA503.41% SMA20010.14% Volume6,433,077 Change-0.30%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Nov-14-18 03:45PM  Jury clears J&J of liability in California talc cancer case Reuters
03:34PM  AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study Zacks
10:52AM  Heres how to easily reduce your investment risk just at the right time MarketWatch
Nov-13-18 09:44PM  [$$] The Theranos tale exposes the dangers lurking in Silicon Valley Financial Times
08:01PM  3 Top Healthcare Stocks to Buy in November Motley Fool
Nov-12-18 05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
11:11AM  Stock Market Power Rankings: Last Call for Facebook Motley Fool
08:00AM  Johnson & Johnson to Participate in the Citi's 2018 Global Healthcare Conference PR Newswire
01:30AM  Singapore National Eye Centre, Singapore Eye Research Institute And Johnson & Johnson Vision Set Sights On Halting Global Myopia Epidemic PR Newswire
Nov-11-18 02:22PM  Hedge Fund Sentiment is Turning Against Johnson & Johnson (JNJ) Insider Monkey
Nov-09-18 10:55AM  7 Dividend Stocks With Rising Payouts InvestorPlace
10:39AM  5 Dow Stocks to Sell (And 2 to Buy) Kiplinger
Nov-08-18 07:13PM  Healthcare ETF (JHMH) Hits New 52-Week High Zacks
10:58AM  Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ Zacks
09:24AM  The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing Zacks
08:42AM  Merck and Johnson & Johnson Shares Show Big Buying Investopedia
08:14AM  Democrats Hold Edge in House Battle: 5 Great Picks (Revised) Zacks
Nov-07-18 06:43PM  Cramer on Washington gridlock: Buy fast growers CNBC Videos
06:39PM  Cramer's advice on investing during Washington gridlock: ... CNBC Videos
04:53PM  Better Buy: Eli Lilly and Company vs. AbbVie Inc. Motley Fool
03:30PM  Dow, Nasdaq Rally Strong As Growth Stocks Show These 5 Bullish Signs Investor's Business Daily
12:36PM  Johnson & Johnson Vision Announces Health Canada has issued a Medical Device License for First-of-its-Kind Contact Lens ACUVUE OASYS with Transitions Light Intelligent Technology CNW Group
12:16PM  'We have a lot of things in common' Trump wants to work with Democrats on infrastructure, drugs CNBC
11:23AM  Here's Why Arrowhead Pharmaceuticals Dropped 33.6% in October Motley Fool
08:31AM  The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter Zacks
07:29AM  5 Top Stocks to Make the Most of a Divided Congress Zacks
Nov-06-18 05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
11:20AM  Beaten-Down Pharma ETFs to Buy Post Q3 Results Zacks
10:09AM  Johnson & Johnson to Participate in the Credit Suisse 27th Annual Healthcare Conference PR Newswire
09:19AM  Two Studies Measure Performance of ACUVUE OASYS with Transitions Light Intelligent Technology Contact Lenses in Simulated Sunlight, Day and Night Driving Conditions PR Newswire
07:00AM  Democrats Hold Edge in House Battle: 5 Great Picks Zacks
Nov-05-18 04:01PM  5 Top Stock Trades for Tuesday: Pepsi Is Strong, but Not Activision InvestorPlace
11:17AM  Jim Cramer: The Stock Market's Machine Buyers TheStreet.com
07:40AM  The Zacks Analyst Blog Highlights: Intel, Exxon Mobil, Johnson & Johnson, JPMorgan and Microsoft Zacks
Nov-02-18 02:23PM  AbbVie sees hit to Humira sales from European competition Reuters
01:23PM  MARKETS: Now Facebook, J&J, Pfizer and Merck are dragging down the market, while Exxon and Chevron are bright spots Yahoo Finance Video
10:50AM  AbbVie Earnings, Revenue beat in Q3 Investing.com
10:42AM  How Geron's Horrible Year Is a Great Reminder to Investors Motley Fool
10:42AM  5 of the Best Blue-Chip Stocks to Ride the Dow Rally Zacks
09:15AM  Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down Zacks
Nov-01-18 08:21PM  Scary Markets, Frightening Stocks, and How to Keep From Panicking Motley Fool
02:55PM  Why Geron Corporation Stock Is Ripping Higher Today Motley Fool
10:08AM  Zoetis Inc Earnings, Revenue beat in Q3 Investing.com
Oct-31-18 06:28PM  Baxter Earnings beat, Revenue misses In Q3 Investing.com
05:25PM  J&J CEO Must Face Questioning Over Baby Powder Statements Bloomberg
02:52PM  The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead Zacks
01:04PM  3 Charts That Suggest It's Time to Buy Healthcare Stocks Investopedia
Oct-30-18 07:06PM  Amgen Earnings, Revenue beat in Q3 Investing.com
03:33PM  Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery? Investor's Business Daily
11:36AM  HCA Earnings, Revenue beat in Q3 Investing.com
09:50AM  Pfizer Earnings beat, Revenue misses In Q3 Investing.com
08:18AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel Zacks
Oct-29-18 05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
04:17PM  Knock Offs Loom For J&J's Blockbuster Why An Analyst Is Still Bullish Investor's Business Daily
04:16PM  Biogen And Eisai May Be At Odds In Alzheimer's So What Now? Investor's Business Daily
03:16PM  Top Stock Picks for the Week of October 29th Zacks
01:31PM  Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel Zacks
11:05AM  Stocks - RedHat Soars in Pre-market, IBM Falls, Tesla, Ford Jump Investing.com
10:17AM  Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more American City Business Journals
09:58AM  What's in the Cards for Geron (GERN) This Earnings Season? Zacks
Oct-28-18 05:48PM  This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You Motley Fool
08:35AM  9 Best Dividend Stocks to Buy for Every Investor InvestorPlace
Oct-27-18 07:00AM  Where Will Gilead Sciences, Inc. Be in 5 Years? Motley Fool
12:07AM  [$$] Bringing Up Babys Market Share at J&J The Wall Street Journal
Oct-26-18 05:48PM  Court Issues Ruling in ZYTIGA® Patent Infringement Litigation PR Newswire
01:51PM  The health and wellness industry is making healthy profits Yahoo Finance Video
01:14PM  'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company Benzinga
11:39AM  Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO Zacks
Oct-25-18 07:32PM  Stryker Earnings beat, Revenue misses In Q3 Investing.com
07:12PM  Gilead Earnings, Revenue beat in Q3 Investing.com
10:40AM  Celgene Earnings, Revenue beat in Q3 Investing.com
09:50AM  Merck&Co Earnings beat, Revenue misses In Q3 Investing.com
09:37AM  J&J Intends to Buy Residual Stake in Japanese Skincare Firm Zacks
08:53AM  3 Beaten-Down Biotech Stocks: Can They Bounce Back? Motley Fool
Oct-24-18 11:05PM  The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18) TheStreet.com
07:24PM  Vertex Earnings, Revenue miss in Q3 Investing.com
09:34AM  Boston Scientific Earnings, Revenue miss in Q3 Investing.com
09:33AM  Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG Zacks
09:04AM  Thermo Fisher Scientific Earnings, Revenue Beats In Q3 Investing.com
Oct-23-18 07:38PM  Edwards Lifesciences Earnings beat, Revenue misses In Q3 Investing.com
06:11PM  The fear gauge and strong earnings tell Jim Cramer this bottom in the stock market may be real CNBC
11:37AM  3 Household Product Stocks to Keep Your Portfolio Clean and Safe Forever InvestorPlace
11:05AM  Why 3M Stock Should Be on Your Wait and See List Again InvestorPlace
10:29AM  Caterpillar Tanks, 3M Slumps Because Trade Woes Are Not Just for China Anymore Barrons.com
10:12AM  Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines Zacks
09:38AM  Biogen Inc Earnings, Revenue beat in Q3 Investing.com
09:34AM  Centene Earnings miss, Revenue beats In Q3 Investing.com
09:31AM  Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT Zacks
07:54AM  J&J moves to buy Japanese cosmetic products company Associated Press
07:46AM  Stocks making the biggest move premarket: UTX, HOG, VZ, MMM, CAT & more CNBC
07:35AM  J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z TheStreet.com
07:19AM  [$$] J&J to Buy Rest of Japanese Beauty Care Company The Wall Street Journal
05:50AM  Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z Reuters
05:44AM  J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z Reuters
03:51AM  Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd. PR Newswire
03:08AM  Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd. PR Newswire
Oct-22-18 05:53PM  Why Aduro Biotech Crashed 29.5% Today Motley Fool
05:45PM  Johnson & Johnson (JNJ) Stock Moves -0.27%: What You Should Know Zacks
07:45AM  Detailed Research: Economic Perspectives on DexCom, MiX Telematics, Resolute Forest Products, Equinix, Johnson & Johnson, and Vedanta What Drives Growth in Today's Competitive Landscape GlobeNewswire
07:18AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Netflix, Microsoft, Amazon and Alphabet Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM